Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 154 participants.
Also called NCT03440268
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 154 participants
- Registry
-
NCT03440268
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Unknown status
Technical summary
Registry record NCT03440268. Randomized; double masking; primary purpose prevention. Start 2018-03-15 (anticipated); primary completion 2019-03-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement
- Condition
- Surgery--Complications
- Condition
- Cardiac Valve Disease
- Condition
- Acute Kidney Injury
- Condition
- Oxygen Radical Damage
- Condition
- Post-Op Complication
- Intervention (Drug)
- N Acetyl Cysteine
- Intervention (Drug)
- Placebos
- Lead sponsor
- University of Sao Paulo General Hospital
Record details
- Record id
cardio:ct-nct03440268- Content hash
3a1e3a52b8864939fa64dcc242ebf934acb0da06fbf3f8a4f2e612cee6dc06c4